City
Epaper

More US states offering boosters amid fear of winter surge

By IANS | Updated: November 18, 2021 08:45 IST

Washington, Nov 18 Amid fear of a Covid-19 resurgence in the upcoming winter season, more states in the ...

Open in App

Washington, Nov 18 Amid fear of a Covid-19 resurgence in the upcoming winter season, more states in the US have started offering booster doses, according to reports.

California made the first move to expand access when public health officials quietly sent a letter to local health jurisdictions and vaccine providers on November 9 instructing them to trust patients to decide whether a booster is appropriate, Xinhua news agency reported on Thursday.

Within days, officials in Colorado, New Mexico, Arkansas, West Virginia and New York City endorsed boosters for all adults.

"More states and jurisdictions are expected to follow," The Washington Post said in a report on Tuesday.

"If you're in doubt and you meet the waiting period, just get a booster. Choose the side of greater protection," Democratic New Jersey Governor Phil Murphy was quoted as saying on Monday.

"With the holidays coming up, we need as many people boosted as possible. It's that simple."

The Food and Drug Administration (FDA) is aiming to authorise booster doses of Pfizer-BioNTech's coronavirus vaccine for all adults as early as Thursday.

A report in The New York Times said that the "move that would expand the number of Americans eligible for additional shots by tens of millions".

The Centers for Disease Control and Prevention's (CDC) independent committee of vaccine experts has scheduled a meeting for Friday to discuss data on the booster dose's efficacy and safety.

If both the FDA and the CDC sign off this week, they will have acted strikingly quickly, a little more than a week after Pfizer asked for authorization of boosters for everyone 18 and older.

Under that scenario, any adult who received a second dose of the vaccine at least six months earlier would be officially eligible to get a booster as soon as this weekend.

The FDA is reportedly expected to rule without consulting its own expert panel, which has met frequently during the pandemic to review vaccine data and make a recommendation ahead of a regulatory decision.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: usXinhuaNew York CityPhil MurphyThe Washington PostPost facebookAmazon washington post
Open in App

Related Stories

InternationalFlorida Shooting: US Rapper Offset Injured at Seminole Hard Rock Hotel & Casino in Hollywood; Two Detained

InternationalMajid Khademi Death: IRGC Intel Chief Killed in US-Israel Attack, Confirms Iran

InternationalLaGuardia Airport Plane Accident: At Least 2 Killed, Several Injured After Air Canada Express CRJ-900 Collides With Fire Truck on Runway

InternationalNew York Plane Accident: At Least 70 Passengers Injured After Air Canada Express Collides With Fire Truck at LaGuardia Airport (Watch Videos)

InternationalUS-Israel-Iran War: Japan, Germany, France Show Caution Over Trump’s Strait of Hormuz Warship Plan

Health Realted Stories

HealthJharkhand HC seeks detailed probe report on HIV-infected blood transfusion in Chaibasa

HealthTejashwi Yadav targets Health Minister Mangal Pandey over viral Gaya hospital video

Health‘Poshan Pakhwada 2026’ to focus on maximising brain development in 1st 6 years of life

HealthTurmeric Milk Benefits: Know When to Drink It for Best Results

HealthWhat Is Second-Hand Stress? How Others’ Anxiety Can Affect Your Mental Health